Original articleSynthesis and biological evaluation of novel dimethyl[1,1′-biphenyl]-2,2′-dicarboxylate derivatives containing thiazolidine-2,4-dione for the treatment of concanavalin A-induced acute liver injury of BALB/c mice

Add time:09/07/2019    Source:sciencedirect.com

In this paper, we reported the synthesis of bifendate derivatives and evaluation of anti-inflammatory activity by detecting the production of the Nitric Oxide (NO) in the lipopolysaccharide(LPS)-stimulated RAW 264.7 cell lines. Among the newly derivatives, compound 7k was the most potent one and two other compounds (7e and 7f) also exhibited greater anti-inflammatory activity than bifendate. Further in vivo studies confirmed that 7k significantly and dose-dependently inhibited carrageenan-induced paw edema and decreased the serum levels of alanine aminotransaminase, and aspartate aminotransaminase in concanavalin A-induced hepatitis model. Histopathological evaluation demonstrated that 7k has better hepatoprotective effect on acute liver injury induced by concanavalin A than bifendate, suggesting that 7k is a potential drug candidate for the treatment of hepatic injuries.

We also recommend Trading Suppliers and Manufacturers of 2-methyl-2,4-thiazolidine dicarboxylate (cas 16708-09-1). Pls Click Website Link as below: cas 16708-09-1 suppliers

Prev:The isolation and identification of 2-methyl-2,4-thiazolidine dicarboxylate (cas 16708-09-1) as a by-product in the conversion of cysteine to glucose in the perfused rat liver
Next:Dimeric argininamide (cas 16709-23-2)-type neuropeptide Y receptor antagonists: Chiral discrimination between Y1 and Y4 receptors)